Cupiennin 1a, an antimicrobial peptide from the venom of the neotropical wandering spider Cupiennius salei, also inhibits the formation of nitric oxide by neuronal nitric oxide synthase

FEBS Journal

Volumn 274, Issue 7, 2007, Pages 1778-1784

  Pukala, Tara L ^a   Doyle, Jason R ^b   Llewellyn, Lyndon E ^b   Kuhn Nentwig, Lucia ^c   Apponyi, Margit A ^a   Separovic, Frances ^d   Bowie, John H ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b AUSTRALIAN INSTITUTE OF MARINE SCIENCE   (Australia)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cupiennin 1a; Cupiennius salei; Neuronal nitric oxide synthase activity; Two dimensional NMR

Indexed keywords

CALMODULIN; CUPIENNIN 1A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYPEPTIDE ANTIBIOTIC AGENT; SPIDER VENOM; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BINDING; COMPLEX FORMATION; CUPIENNIUS SALEI; DRUG SCREENING; ENZYME INHIBITION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPIDER; STOICHIOMETRY;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CALCIUM; CALMODULIN; ENZYME INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PEPTIDES; PROTEIN BINDING; SPIDER VENOMS; SPIDERS;

ARANEAE; CTENIDAE; CUPIENNIUS SALEI;

EID: 33947217296     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05726.x     Document Type: Article

References (37)

1. Barth FG (2002) A Spider's World. Senses and Behaviour. Springer-Verlag, Berlin.
2. Kuhn-Nentwig L, Schaller J & Nentwig W (2004) Biochemistry, toxicology and ecology of the venom of the spider Cupiennius salei (Ctenidae). Toxicon 43, 543-553.
3. Kuhn-Nentwig L, Schaller J & Nentwig W (1994) Purification of toxic peptides and the amino acid sequence of CSTX-1 from the multicomponent venom of Cupiennius salei (Ctenidae). Toxicon 32, 287-302.
4. Wullschleger B, Kuhn-Nentwig L, Tromp J, Kanpfer U, Schaller J, Schurch S & Nentwig W (2004) CSTG-13, a highly synergistically acting two-chain neurotoxic enhancer in the venom of the spider Cupiennius salei (Ctenidae). Proc Natl Acad Sci USA 101, 11251-11256.
5. Haeberli S, Kuhn-Nentwig L, Schaller J & Nentwig W (2000) Characterisation of antibacterial activity of peptides isolated from the venom of the spider Cupiennius salei (Ctenidae). Toxicon 38, 373-380.
6. Kuhn-Nentwig L, Müller J, Schaller J, Walz A, Dathe M & Nentwig W (2002) Cupiennin 1, a new family of highly basic antimicrobial peptides in the venom of Cupiennius salei (Ctenidae). J Biol Chem 277, 11208-11216.
7. Kuhn-Nentwig (2003) Antimicrobial and cytolytic peptides of venomous arthropods. Cell Mol Life Sci 60, 2651-2668.
8. Wullschleger B, Nentwig W & Kuhn-Nentwig L (2005) Spider venom: enhancement of venom efficacy mediated by different synergistic strategies in Cupiennius salei. J Expt Biol 208, 2115-2121.
9. Pukala TL, Boland M, Gehman JD, Kuhn-Nentwig L, Separovic F & Bowie JH (2006) Solution structure and interaction of cupiennin 1a, a spider venom peptide, with phospholipid bilayers. Biochemistry in press.
10. Doyle JR, Llewellyn LE, Brinkworth CS, Bowie JH, Wegener KL, Rozek T, Wabnitz PA, Wallace JC & Tyler MJ (2002) Amphibian peptides that inhibit nNOS. The isolation of lesueurin from the skin secretion of the Australian Stony Creek Frog Litoria lesueuri. Eur J Biochem 269, 100-109.
11. Pukala TL, Bowie JH, Maselli VM, Musgrave IF & Tyler MJ (2006) Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat Prod Rep 23, 368-393.
12. Fersht A (1985) Cooperative ligand binding and allosteric interactions in enzyme structure and mechanism. In Enzyme Structure and Mechanism, pp. 208-225. Freeman WH, New York, NY.
13. Schon O, Friedler A, Freund S & Fersht AR (2004) Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes. J Mol Biol 336, 197-202.
14. 15N spectra of larger proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Application to calmodulin. Biochemistry 29, 4659-4667.
15. Torizawa T, Shimizu M, Taoka M, Miyano H & Kainosho M (2004) Efficient production of isotopically labelled proteins by cell free synthesis: a practical protocol. J Biomol NMR 30, 311-325.
16. Kerwin JF, Lancaster JR & Feldman PL (1995) Nitric oxide: a new paradigm for secondary messengers. J Med Chem 38, 4344-4362.
17. Stuehr DJ & Ghosh S (2000) Nitric Oxide. Handbook of Experimental Pharmacology (Mayer B, ed.), pp. 33-70. Springer-Verlag, Berlin.
18. Choi WS, Chang MS, Han JW, Hong SY & Lee HW (1997) Identification of NOS in Staphylococcus aureus. Biochem Biophys Res Commun 237, 554-558.
19. Morita H, Yoshikawa H, Sakata R, Nagata Y & Tanaka H (1997) Synthesis of nitric oxide from the two equivalent quanidino nitrogens of L-arginine by Lactobacillus fermentum. J Bacteriol 179, 7812-7815.
20. Choi WS, Seo DW, Chang MS, Han JW, Paik WK & Lee HW (1998) Methyl esters of L-arginine and N-nitro-L-arginine induce NOS in Staphylococcus aureus. Biochem Biophys Res Commun 246, 431-435.
21. Er H, Turkoz Y, Ozerol IH & Uzmez E (1998) Effect of NOS inhibition in experimental Pseudomonas keratitis in rabbits. Eur J Opthalmol 8, 137-141.
22. 2+ calmodulin-dependent nitric oxide synthase in Apis mellifera and Drosophila melanogaster. Eur J Neurosci 6, 1362-1370.
23. 2+ calmodulin-dependent nitric oxide synthase. Proc Natl Acad Sci USA 92, 9072-9076.
24. D'yakonova VE & Krushinskii AL (2006) Effects of an NOS inhibitor on aggressive and sexual behaviour in male crickets. Neurosci Behav Physiol 36, 565-571.
25. Ikura M, Clore GM, Gronenborn AM, Zhu G, Klee CB & Bax A (1992) Solution structure of a calmodulin target peptide complex by multidimensional NMR. Science 256, 632-638.
26. 2+ pump. Biochemistry 38, 12320-12332.
27. Klee CB & Vanaman TC (1982) Calmodulin. Adv Prot Chem 35, 213-219.
28. Chin D & Means AR (2000) Calmodulin: a prototypical calcium sensor. Cell Biol 10, 322-328.
29. Hoedlich KP & Ikura M (2002) Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108, 739-742.
30. Vetter SW & Leclerc E (2003) Novel aspects of calmodulin target recognition and activation. Eur J Biochem 270, 404-414.
31. Roth SM, Schmeider DM, Strobel L, van Berkum M, Means A & Wand AJ (1991) Structure of the smooth muscle myosin light-chain kinase calmodulin-binding domain peptide bound to calmodulin. Biochemistry 30, 10078-10084.
32. Meador WE, Means AR & Quiocho FA (1992) Target enzyme recognition by calmodulin: 2.4 Å structure of a calmodulin peptide complex. Science 257, 1251-1255.
33. Aoyagi M, Arvai AS, Tainer JA & Getzoff ED (2003) Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO J 22, 766-775.
34. Kataoka M, Head JF, Vorherr T, Krebs J & Carafoli E (1991) Small-angle X-ray scattering study of calmodulin bound to two peptides corresponding to parts of the calmodulin-binding domain of the plasma membrane Ca-pump. Biochemistry 30, 6247-6251.
35. Ikura M, Kay LE, Krinks M & Bax A (1991) Triple-resonance multidimensional NMR study of calmodulin complexed with the binding domain of skeletal muscle myosin light-chain kinase: indication of a conformational change in the central helix. Biochemistry 30, 5498-5504.
36. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J & Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277-293.
37. Goddard TD, Kneller DG (2006). SPARKY 3. University of California, San Francisco, CA.